The National Academy of Medicine elects two global leaders in cellular and gene therapy from Children’s Hospital of Philadelphia.

Beverly L. Davidson, PhD, director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics has been elected into the National Academy of Medicine (NAM).

Stephan Grupp, MD, PhD, Chief of the Cell Therapy and Transplant Section in the Division of Oncology, has been elected into the National Academy of Medicine (NAM).

Julie Brothers, M.D., F.A.A.P. spoke to MedPage Today about the clinical challenges of pediatric hyperlipidemia.

Does Home-based Digital Urinalysis Technology Enhance Clinical Experience and Workflows for Patients and Providers?

The Wyss Medical Foundation gifted CHOP $5 million to support thoracic insufficiency syndrome (TIS) patient care, innovative research and education at CHOP.

The Fetal Heart Program at CHOP is one of the first programs in the world to begin incorporating provocative testing with maternal hyperoxygenation in our fetal echocardiography imaging suite.

The Fetal Heart Program provides comprehensive, compassionate care that addresses the medical as well as psychosocial effects of a family’s experience in the setting of a fetal congenital heart disease diagnosis.

Data collected by CHOP's new Birth Defects Biorepository will be used to investigate factors that may cause birth defects and that may modify the long-term outcomes.

This case highlights the complex, multidisciplinary care required for prenatal management, delivery and immediate cardiac intervention for pulmonary arterio-venous fistula (PAVF).